# Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes

> **NCT06181721** · NA · COMPLETED · sponsor: **Insulet Corporation** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Omnipod 5 Automated Glucose Control System

## Key facts

- **NCT ID:** NCT06181721
- **Lead sponsor:** Insulet Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-05
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181721, "Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06181721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*